Form 4 for OCUL OCULAR THERAPEUTIX, INC
Accepted 2023-07-12 00:00:00 ET · period of report 2023-07-10 · accession 0001104659-23-080407 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-07-12 | 2023-07-10 | OCUL | Graves Adrienne L | Dir | A - Grant | $0.00 | +24.0K | 24.0K | New | $0 |
| D | 2023-07-12 | 2023-07-10 | OCUL | Graves Adrienne L | Dir | A - Grant | $0.00 | +72.0K | 72.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-10 | A | A | 24,000 | $0.00 | 24,000 | D | — | — | (F1) On July 10, 2023, the reporting person was granted restricted stock units ("RSUs") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Company"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service on the Company's board of directors, the RSUs will vest over three years, vesting 1/3 on each yearly anniversary of the date of grant. |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-07-10 | A | A | 72,000 | $0.00 | 72,000 | D | $5.04 · — to 2033-07-09 | 72,000 Common Stock | (F2) Subject to the reporting person's continued service on the Company's board of directors, the options will vest over three years, vesting 1/3 on each yearly anniversary of the date of grant. |